Shanghai Pharmaceuticals Holding Co., Ltd Stock
Stocks
601607
CNE000000C82
Pharmaceuticals
OTC Markets Traded|
End-of-day quote
Shanghai S.E.
2026-11-11
|
5-day change | 1st Jan Change | ||
| 16.21 CNY | -1.40% |
|
-4.48% | -9.24% |
| 11-04 | Shanghai Pharmaceuticals Gets China Clinical Trial Nod for Hypertension Inhalation Powder | MT |
| 11-04 | Shanghai Pharmaceuticals' Parent Raises Stake for 8.8 Million Yuan | MT |
| Market Cap | 53.84B 8.06B 7.27B 6.72B 6.07B 11.49B 756B 11.77B 80.48B 32.08B 405B 30.27B 29.62B 1,289B | P/E 2026 * |
11.1x | P/E 2027 * | 10.4x |
|---|---|---|---|---|---|
| Enterprise Value | 56.31B 8.43B 7.6B 7.02B 6.35B 12.01B 791B 12.31B 84.17B 33.55B 424B 31.65B 30.98B 1,348B | EV / Sales 2026 * |
0.19x | EV / Sales 2027 * | 0.21x |
| Free-Float |
41.21% | Yield 2026 * |
2.78% | Yield 2027 * | 2.96% |
| 1 day | -1.40% | ||
| 1 week | -4.48% | ||
| Current month | -1.88% | ||
| 1 month | -2.82% | ||
| 3 months | -3.05% | ||
| 6 months | -5.04% | ||
| Current year | -9.24% |
| 1 week | 16.18 |  | 16.95 |
| 1 month | 16 | | 17.1 |
| Current year | 15.01 | | 18.13 |
| 1 year | 15.01 | | 18.56 |
| 3 years | 15.01 | | 23.2 |
| 5 years | 15.01 | | 28.64 |
| 10 years | 15.01 | | 29.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ya Dong Zhou
DFI | Director of Finance/CFO | 54 | 2026-06-24 |
Yong Zhong Li
PSD | President | 56 | 2023-06-28 |
Bo Shen
DFI | Director of Finance/CFO | 53 | 2013-06-04 |
| Director | Title | Age | Since |
|---|---|---|---|
Bo Shen
BRD | Director/Board Member | 53 | 2016-06-27 |
Yong Zhong Li
BRD | Director/Board Member | 56 | 2019-06-26 |
Ming Dong
BRD | Director/Board Member | 49 | 2023-06-28 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/17/25 | Other | Chairperson | 132,600 | 0.0144% | ||
| 4/17/25 | Other | Chairperson | 132,600 | 0.0144% | ||
| 4/18/24 | Other | Chairperson | 128,700 | 0.0067% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.40% | -4.48% | -11.28% | -10.89% | 8.18B | |
| +0.35% | +1.36% | +45.38% | +134.58% | 1,276B | |
| -0.13% | +1.48% | +44.67% | +89.94% | 676B | |
| +0.37% | +0.05% | +31.00% | +112.77% | 519B | |
| +0.02% | +2.79% | +44.10% | +69.76% | 388B | |
| -0.59% | -2.11% | +61.83% | +43.63% | 365B | |
| -1.29% | +0.94% | +29.88% | +58.29% | 307B | |
| +0.09% | +0.99% | +5.87% | +37.72% | 287B | |
| +0.62% | -2.17% | +38.31% | +75.53% | 252B | |
| -0.67% | -2.72% | +38.49% | +126.52% | 212B | |
| Average | +0.00% | +1.75% | +32.83% | +73.78% | 429B | |
| Weighted average by Cap. | +0.11% | +2.50% | +40.20% | +95.22% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 295B 44.24B 39.88B 36.84B 33.3B 63.01B 4,149B 64.56B 442B 176B 2,222B 166B 163B 7,072B | 314B 47.04B 42.4B 39.17B 35.41B 66.99B 4,412B 68.65B 469B 187B 2,363B 177B 173B 7,520B |
| Net income | 5.5B 823M 742M 686M 620M 1.17B 77.24B 1.2B 8.22B 3.28B 41.36B 3.09B 3.02B 132B | 5.8B 869M 783M 724M 654M 1.24B 81.5B 1.27B 8.67B 3.46B 43.65B 3.26B 3.19B 139B |
| Net Debt | 2.46B 369M 333M 307M 278M 526M 34.62B 539M 3.68B 1.47B 18.54B 1.39B 1.36B 59.01B | 12.26B 1.84B 1.66B 1.53B 1.38B 2.62B 172B 2.68B 18.33B 7.3B 92.25B 6.89B 6.75B 294B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-11-10 | CN¥16.21 | -1.40% | 14,244,900 |
| 26-11-10 | CN¥16.44 | -0.60% | 9,973,214 |
| 26-11-09 | CN¥16.54 | -1.31% | 11,164,280 |
| 26-11-06 | CN¥16.76 | -0.30% | 10,000,093 |
| 26-11-05 | CN¥16.81 | -0.30% | 14,214,427 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- 601607 Stock
Select your edition
All financial news and data tailored to specific country editions
